当前位置： SCI文献检索 > GENE THERAPY期刊下所有文献 > Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein.

Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein.

Abstract：

:We report on long-term delivery of an interferon-gamma (IFN gamma) inhibitory protein by intramuscular (i.m.) gene therapy. IFN gamma is a cytokine that plays an important role in many inflammatory disorders, including autoimmune insulin-dependent diabetes mellitus (IDDM) in NOD mice and (in various strains) multiple low-dose streptozotocin (STZ)-induced diabetes (MDSD). By cDNA insertion into plasmid VICAL VR-1255 we constructed an expression vector encoding a soluble IFN gamma receptor/IgG1 heavy chain (all murine) fusion protein (IFN gamma R/IgG1). This protein is secreted as a homodimer and neutralizes IFN gamma in vitro. We show that i.m. injections of this vector as naked DNA in mice results in secretion of IFN gamma R/IgG1, with serum levels exceeding 100 ng/ml for months after treatment. These levels are sufficient to neutralize IFN gamma in vivo, and to prevent either MDSD or cyclophosphamide (CYP)-accelerated diabetes in NOD mice, which are both characterized by systemic release of IFN gamma. In these diseases gene therapy considerably reduces inflammation in the islets of Langerhans (insulitis). Also, circulating IFN gamma R/IgG1 blocked IFN gamma-enhanced nitric oxide production by peritoneal macrophages. The fusion protein is constructed from non-immunogenic self elements, avoiding a neutralizing immune response and making it suitable for prolonged therapy of numerous inflammatory disorders.

journal_name

Gene Ther

journal_title

Gene therapy

authors

Prud'homme GJ,Chang Y

doi

10.1038/sj.gt.3300879

keywords:

subject

Has Abstract

pub_date

1999-05-01 00:00:00

pages

771-7

issue

5

eissn

0969-7128

issn

1476-5462

journal_volume

6

pub_type

杂志文章

相关文献

GENE THERAPY文献大全
  • Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.

    abstract：:Rescue of dystrophic skeletal muscle in mdx and utrophin/dystrophin-deficient (dko) mouse models by reintroduction of dystrophin has validated gene therapy as a potential therapeutic approach for Duchenne muscular dystrophy. However, the size of the dystrophin gene exceeds the capacity of adeno-associated viral (AAV) ...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302686

    authors： Gardner KL,Kearney JA,Edwards JD,Rafael-Fortney JA

    更新日期：2006-05-01 00:00:00

  • Gene therapy progress and prospects: RNA aptamers.

    abstract：:Aptamers are oligonucleotides evolved in vitro or in nature to bind target ligands with high affinity and specificity. They are emerging as powerful tools in the fields of therapeutics, drug development, target validation and diagnostics. Aptamers are attractive alternatives to antibody- and small-molecule-based thera...

    journal_title：Gene therapy

    pub_type： 杂志文章,评审

    doi：10.1038/sj.gt.3302900

    authors： Que-Gewirth NS,Sullenger BA

    更新日期：2007-02-01 00:00:00

  • Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial.

    abstract：:Both replication-incompetent and replication-selective adenoviruses are being developed for the treatment of cancer and other diseases. Concerns have been raised about the safety of intra-vascular adenovirus administration following a patient death on a clinical trial with a replication-defective adenovirus. In additi...

    journal_title：Gene therapy

    pub_type： 临床试验,杂志文章

    doi：10.1038/sj.gt.3301512

    authors： Reid T,Galanis E,Abbruzzese J,Sze D,Andrews J,Romel L,Hatfield M,Rubin J,Kirn D

    更新日期：2001-11-01 00:00:00

  • T-cell response to adenovirus hexon and DNA-binding protein in mice.

    abstract：:The successful development of adenovirus vectors for vaccines and gene therapy will require a better understanding of the host immune response. Using the ELISPOT assay to measure IFN-gamma-secreting CD8(+) cells, we identify immunodominant epitopes of the adenovirus hexon and DNA-binding protein in BALB/c and C57BL/6 ...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302232

    authors： McKelvey T,Tang A,Bett AJ,Casimiro DR,Chastain M

    更新日期：2004-05-01 00:00:00

  • Folate receptor mediated DNA delivery into tumor cells: potosomal disruption results in enhanced gene expression.

    abstract：:We have used a particular folate receptor, which is overexpressed in tumor cells, for targeted DNA delivery into these cell types. This folate receptor internalizes folate through caveolae by a process named potocytosis, which is distinct from endocytosis, through clathrin-coated pits. When folate conjugated to poly-L...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：

    authors： Gottschalk S,Cristiano RJ,Smith LC,Woo SL

    更新日期：1994-05-01 00:00:00

  • Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat.

    abstract：:Bone morphogenetic protein (BMP) adenoviral vectors for the induction of osteogenesis are being developed for the treatment of bone pathology. However, it is still unknown which BMP adenoviral vector has the highest potential to stimulate bone formation in vivo. In this study, the osteogenic activities of recombinant ...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302075

    authors： Li JZ,Li H,Sasaki T,Holman D,Beres B,Dumont RJ,Pittman DD,Hankins GR,Helm GA

    更新日期：2003-09-01 00:00:00

  • Understanding the molecular biology of intervertebral disc degeneration and potential gene therapy strategies for regeneration: a review.

    abstract：:Intervertebral disc degeneration (IVDD) is a multi-factorial process characterized by phenotypic and genotypic changes, which leads to low back pain and disability. Prolonged imbalance between anabolism and catabolism in discs alters their composition resulting in progressive loss of proteoglycans and hydration leadin...

    journal_title：Gene therapy

    pub_type： 信件,评审

    doi：10.1038/s41434-018-0004-0

    authors： Sampara P,Banala RR,Vemuri SK,Av GR,Gpv S

    更新日期：2018-04-01 00:00:00

  • Imaging and tissue biodistribution of 99mTc-labeled adenovirus knob (serotype 5).

    abstract：:Hepatic sequestration of systemically administered adenoviral vectors reduces the number of viral particles available for delivery to other tissues. The biological basis of this phenomenon was investigated using a new in vivo technique which permitted imaging in real time. Recombinant adenovirus serotype 5 knob (Ad5K)...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3300659

    authors： Zinn KR,Douglas JT,Smyth CA,Liu HG,Wu Q,Krasnykh VN,Mountz JD,Curiel DT,Mountz JM

    更新日期：1998-06-01 00:00:00

  • Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo.

    abstract：:Cytomegalovirus (CMV) promoter is often present in recombinant adenovirus vectors (AdVs) suitable for gene therapy, ensuring high levels of transgene production in a wide range of hosts. Despite this characteristic, the presence of the AdV genome in target cells and tissues typically lasts longer than transgene produc...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3301296

    authors： Gaetano C,Catalano A,Palumbo R,Illi B,Orlando G,Ventoruzzo G,Serino F,Capogrossi MC

    更新日期：2000-10-01 00:00:00

  • Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy.

    abstract：:Advances in islet transplantation have encouraged efforts to create alternative insulin-secreting cells that overcome limitations associated with current therapies. We have recently demonstrated durable correction of murine and porcine diabetes by syngeneic and autologous implantation, respectively, of primary hepatoc...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2010.12

    authors： Chen NK,Tan SY,Udolph G,Kon OL

    更新日期：2010-05-01 00:00:00

  • Antimonocyte chemoattractant protein-1 gene therapy reduces experimental in-stent restenosis in hypercholesterolemic rabbits and monkeys.

    abstract：:In-stent restenosis results exclusively from neointimal hyperplasia due to mechanical injury and a foreign body response to the prosthesis. Inflammation mediated by monocyte chemoattractant protein-1 (MCP-1) might therefore underlie in-stent restenosis. We recently devised a new strategy for anti-MCP-1 gene therapy by...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302288

    authors： Ohtani K,Usui M,Nakano K,Kohjimoto Y,Kitajima S,Hirouchi Y,Li XH,Kitamoto S,Takeshita A,Egashira K

    更新日期：2004-08-01 00:00:00

  • Safety of a single aerosol administration of escalating doses of the cationic lipid GL-67/DOPE/DMPE-PEG5000 formulation to the lungs of normal volunteers.

    abstract：:Several groups are assessing the use of cationic lipids for respiratory gene therapy. To date no human data are available regarding the safety of intra-pulmonary cationic lipid delivery. In preparation for a trial of pulmonary delivery of the CFTR gene, we have assessed the safety of nebulised lipid GL-67/DOPE/DMPE-PE...

    journal_title：Gene therapy

    pub_type： 临床试验,杂志文章

    doi：10.1038/sj.gt.3300481

    authors： Chadwick SL,Kingston HD,Stern M,Cook RM,O'Connor BJ,Lukasson M,Balfour RP,Rosenberg M,Cheng SH,Smith AE,Meeker DP,Geddes DM,Alton EW

    更新日期：1997-09-01 00:00:00

  • Analysis of human immunodeficiency virus type 1 vector cis- and trans-acting elements production by means of Semliki Forest virus.

    abstract：:Recombinant Semliki Forest virus (SFV) is an attractive viral vector system owing to its ability to allow high efficiency of viral protein expression. To produce recombinant pseudotyped human immunodeficiency virus type 1 (HIV-1) virions, we designed a chimeric SFV/HIV vector system that contains both the HIV-1 cis- a...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2008.159

    authors： Del Vecchio C,Calistri A,Lombardi G,Celegato M,Biasolo MA,Palù G,Parolin C

    更新日期：2009-02-01 00:00:00

  • Novel degradable oligoethylenimine acrylate ester-based pseudodendrimers for in vitro and in vivo gene transfer.

    abstract：:A novel class of cationic hyperbranched polymers, containing branched oligoethylenimine (OEI 800 Da) as core, diacrylate esters as linkers and oligoamines as surface modification, was synthesized and evaluated regarding their structure-activity relationship as gene carriers. We show that pseudodendritic core character...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3303046

    authors： Russ V,Elfberg H,Thoma C,Kloeckner J,Ogris M,Wagner E

    更新日期：2008-01-01 00:00:00

  • Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion.

    abstract：:betaTC-tet cells are conditionally immortalized pancreatic beta cells which can confer long-term correction of hyperglycemia when transplanted in syngeneic streptozocin diabetic mice. The use of these cells for control of type I diabetes in humans will require their encapsulation and transplantation in non-native site...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3300922

    authors： Dupraz P,Rinsch C,Pralong WF,Rolland E,Zufferey R,Trono D,Thorens B

    更新日期：1999-06-01 00:00:00

  • Disease-causing allele-specific silencing against the ALK2 mutants, R206H and G356D, in fibrodysplasia ossificans progressiva.

    abstract：:Fibrodysplasia ossificans progressiva (FOP) is an autosomal dominant congenital disorder characterized by progressive heterotopic bone formation. Currently, no definitive treatment exists for FOP. The activin receptor type IA / activin-like kinase 2 (ACVR1/ALK2) gene has been identified as the responsible gene for FOP...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2011.193

    authors： Takahashi M,Katagiri T,Furuya H,Hohjoh H

    更新日期：2012-07-01 00:00:00

  • Foamy virus--adenovirus hybrid vectors.

    abstract：:To confer adenovirus vectors (AdV), the feature of integration into the host cell genome hybrid vectors were characterized in vitro, which express vectors derived from the prototypic foamy virus (FV) in the backbone of a high-capacity AdV. FVs constitute a subfamily of retroviruses with a distinct replication pathway ...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302216

    authors： Picard-Maureau M,Kreppel F,Lindemann D,Juretzek T,Herchenröder O,Rethwilm A,Kochanek S,Heinkelein M

    更新日期：2004-04-01 00:00:00

  • Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.

    abstract：:Gene therapy of cystic fibrosis (CF) lung disease needs highly efficient delivery and long-lasting complementation of the CFTR (cystic fibrosis transmembrane conductance regulator) gene into the respiratory epithelium. The development of lentiviral vectors has been a recent advance in the field of gene transfer and th...

    journal_title：Gene therapy

    pub_type： 杂志文章,评审

    doi：10.1038/sj.gt.3302372

    authors： Copreni E,Penzo M,Carrabino S,Conese M

    更新日期：2004-10-01 00:00:00

  • Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.

    abstract：:Until recently, adeno-associated virus 9 (AAV9) was considered the AAV serotype most effective in crossing the blood-brain barrier (BBB) and transducing cells of the central nervous system (CNS), following systemic injection. However, a newly engineered capsid, AAV-PHP.B, is reported to cross the BBB at even higher ef...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/s41434-018-0005-z

    authors： Rincon MY,de Vin F,Duqué SI,Fripont S,Castaldo SA,Bouhuijzen-Wenger J,Holt MG

    更新日期：2018-04-01 00:00:00

  • Evidence for localization of biologically active recombinant retroviral vector to lymph nodes in mice injected intramuscularly.

    abstract：:We have developed a novel gene transfer drug, HIV-IT(V), for the treatment of HIV infection in humans. HIV-IT(V) is a retroviral vector encoding the HIV-1 IIIB env and rev genes and a neomycin resistance marker gene (neor). We have recently reported that HIV-IT(V) administered intramuscularly to male mice localizes pr...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：

    authors： Kamantigue E,Edwards W 3rd,Chada S,Brumm D,Austin M,Irwin M,Mento S,Kowal K,Sajjadi N

    更新日期：1996-02-01 00:00:00

  • Replication-competent retrovirus produced by a 'split-function' third generation amphotropic packaging cell line.

    abstract：:We report the discovery, on routine screening, of a replication-competent retrovirus (RCR) produced from a third generation amphotropic packaging cell line, GP + envAM12. In this line, the gag-pol and env helper genes are located on separate plasmids to minimise the chances of recombination events that may lead to RCR...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：

    authors： Chong H,Vile RG

    更新日期：1996-07-01 00:00:00

  • Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors.

    abstract：:Lentivirus can be engineered to be a highly potent vector for gene therapy applications. However, generation of clinical grade vectors in enough quantities for therapeutic use is still troublesome and limits the preclinical and clinical experiments. As a first step to solve this unmet need we recently introduced a bac...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2010.162

    authors： Lesch HP,Laitinen A,Peixoto C,Vicente T,Makkonen KE,Laitinen L,Pikkarainen JT,Samaranayake H,Alves PM,Carrondo MJ,Ylä-Herttuala S,Airenne KJ

    更新日期：2011-06-01 00:00:00

  • Utility of Epstein-Barr virus-encoded small RNA promoters for driving the expression of fusion transcripts harboring short hairpin RNAs.

    abstract：:To induce RNA interference (RNAi), either small interfering RNAs (siRNAs) are directly introduced into the cell or short hairpin RNAs (shRNAs) are expressed from a DNA vector. At present, shRNAs are commonly synthesized by RNA polymerase III (Pol III) promoters of the H1 and U6 RNAs. In this study, we designed and cha...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3303055

    authors： Choy EY,Kok KH,Tsao SW,Jin DY

    更新日期：2008-02-01 00:00:00

  • Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium.

    abstract：:We investigated the efficiency of activated polyamidoamine dendrimers, a new class of nonviral vectors, to transfect rabbit and human corneas in ex vivo culture. In addition to assessing the expression of a marker gene we have demonstrated that this approach can be used to induce the production of TNF receptor fusion ...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3300886

    authors： Hudde T,Rayner SA,Comer RM,Weber M,Isaacs JD,Waldmann H,Larkin DF,George AJ

    更新日期：1999-05-01 00:00:00

  • Therapeutic expression of hairpins targeting apolipoprotein B100 induces phenotypic and transcriptome changes in murine liver.

    abstract：:Constitutive expression of short hairpin RNAs (shRNAs) may cause cellular toxicity in vivo and using microRNA (miRNA) scaffolds can circumvent this problem. Previously, we have shown that embedding small interfering RNA sequences targeting apolipoprotein B100 (ApoB) in shRNA (shApoB) or miRNA (miApoB) scaffolds result...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2013.58

    authors： Maczuga P,Verheij J,van der Loos C,van Logtenstein R,Hooijer G,Martier R,Borel F,Lubelski J,Koornneef A,Blits B,van Deventer S,Petry H,Konstantinova P

    更新日期：2014-01-01 00:00:00

  • Generation of human TRIM5alpha mutants with high HIV-1 restriction activity.

    abstract：:Rhesus macaque tripartite motif (TRIM)5alpha potently inhibits early stages of human immunodeficiency virus (HIV)-1 replication, while the human orthologue has little effect on this virus. We used PCR-based random mutagenesis to construct a large library of human TRIM5alpha variants containing mutations in the PRYSPRY...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/gt.2010.40

    authors： Pham QT,Bouchard A,Grütter MG,Berthoux L

    更新日期：2010-07-01 00:00:00

  • Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.

    abstract：:We have developed synthetic double-stranded oligodeoxynucleotides (ODN) as 'decoy' cis elements that block the binding of nuclear factors to promoter regions of targeted genes, resulting in the inhibition of gene transactivation in vivo. In the present study, we employed decoy ODN targeting the transcription factor nu...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3301478

    authors： Kawamura I,Morishita R,Tsujimoto S,Manda T,Tomoi M,Tomita N,Goto T,Ogihara T,Kaneda Y

    更新日期：2001-06-01 00:00:00

  • Isolated limb perfusion: a novel delivery system for wild-type p53 and fiber-modified oncolytic adenoviruses to extremity sarcoma.

    abstract：:Isolated limb perfusion (ILP) is a limb salvage surgical modality used to deliver chemotherapy and biologic agents to locally advanced and recurrent extremity soft tissue sarcoma (STS), and may be readily tailored for delivery of gene therapy. We set out to test the feasibility of delivering AdFLAGp53 (replication inc...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3302911

    authors： Hannay J,Davis JJ,Yu D,Liu J,Fang B,Pollock RE,Lev D

    更新日期：2007-04-01 00:00:00

  • Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450.

    abstract：:The prognosis of pancreatic adenocarcinoma is poor and current treatment ineffective. A novel treatment strategy is described here using a mouse model system for pancreatic cancer. Cells that have been genetically modified to express the cytochrome P450 2B1 enzyme are encapsulated in cellulose sulphate and implanted i...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3300671

    authors： Löhr M,Müller P,Karle P,Stange J,Mitzner S,Jesnowski R,Nizze H,Nebe B,Liebe S,Salmons B,Günzburg WH

    更新日期：1998-08-01 00:00:00

  • Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor.

    abstract：:A retroviral vector constructed from the murine leukemia virus (MLV) can only express transgenes in cells undergoing mitosis, indicating its suitability as a delivery vehicle for cancer gene therapy. However, the transduction efficiency (TE) of retroviruses embedding endogenous envelope proteins in human cancer cells ...

    journal_title：Gene therapy

    pub_type： 杂志文章

    doi：10.1038/sj.gt.3301390

    authors： Lee H,Song JJ,Kim E,Yun CO,Choi J,Lee B,Kim J,Chang JW,Kim JH

    更新日期：2001-02-01 00:00:00